trending Market Intelligence /marketintelligence/en/news-insights/trending/4cP1ex8O3ib6RXxxMCm2CQ2 content esgSubNav
In This List

Regulus Therapeutics receives Nasdaq noncompliance notice

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation

Blog

Using Credit Analytics to Avoid Mispricing Insurance Premiums

Blog

Post-Webinar Q&A: Integrating Climate Risks into Credit Risk Portfolios


Regulus Therapeutics receives Nasdaq noncompliance notice

Regulus Therapeutics Inc. received a notice from the Nasdaq Stock Market for failing to meet the exchange's $1 minimum bid price listing requirement.

The company has 180 days to regain compliance.

The notice has no effect on the company's common stock listing at the time.